StonvexLoading…
StonvexStonvexStonvexCore line items from AIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.60M | $6.70M | $2.70M | $0.00 |
Operating Income | $-15.85M | $117.69M | $113.28M | $118.55M |
Net Income | $547.16M | $-103.99M | $-166.20M | $74.64M |
EPS (Diluted) | $3.87 | $-0.75 | $-1.16 | $3.87 |
Total Assets | $1.68B | $1.96B | $2.09B | $2.18B |
Total Liabilities | $1.12B | $1.64B | $1.50B | $1.39B |
Cash & Equivalents | $394.89M | $141.07M | $122.60M | $206.46M |
Free Cash Flow OCF − CapEx | $-91.53M | $-113.04M | $-222.03M | $-33.29M |
Shares Outstanding | 140.16M | 136.35M | 140.58M | 146.52M |